Thread: AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS)
View Single Post
Old 05-19-2017, 01:23 PM
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,277
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,277
15 yr Member
Exclamation AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS)
AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting

Study was a success showing masitinib to be a safe and effective treatment in ALS


AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting Paris Stock Exchange:AB.PA
MuonOne is offline   Reply With QuoteReply With Quote